- Home
- LGCB vs ADAP Comparison
LGCB vs ADAP Comparison
Compare LGCB & ADAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGCB
- ADAP
- Stock Information
- Founded
- LGCB 2011
- ADAP 2008
- Country
- LGCB Japan
- ADAP United Kingdom
- Employees
- LGCB N/A
- ADAP N/A
- Industry
- LGCB
- ADAP Biotechnology: Pharmaceutical Preparations
- Sector
- LGCB
- ADAP Health Care
- Exchange
- LGCB Nasdaq
- ADAP Nasdaq
- Market Cap
- LGCB 20.0M
- ADAP 21.3M
- IPO Year
- LGCB 2023
- ADAP 2015
- Fundamental
- Price
- LGCB $2.27
- ADAP $0.06
- Analyst Decision
- LGCB
- ADAP Hold
- Analyst Count
- LGCB 0
- ADAP 6
- Target Price
- LGCB N/A
- ADAP $1.02
- AVG Volume (30 Days)
- LGCB 6.3K
- ADAP 89.0M
- Earning Date
- LGCB 07-03-2025
- ADAP 08-13-2025
- Dividend Yield
- LGCB N/A
- ADAP N/A
- EPS Growth
- LGCB N/A
- ADAP N/A
- EPS
- LGCB N/A
- ADAP N/A
- Revenue
- LGCB $8,993,265.00
- ADAP $65,084,999.00
- Revenue This Year
- LGCB N/A
- ADAP N/A
- Revenue Next Year
- LGCB N/A
- ADAP $52.35
- P/E Ratio
- LGCB N/A
- ADAP N/A
- Revenue Growth
- LGCB 5.80
- ADAP N/A
- 52 Week Low
- LGCB $1.22
- ADAP $0.05
- 52 Week High
- LGCB $19.00
- ADAP $1.33
- Technical
- Relative Strength Index (RSI)
- LGCB 41.09
- ADAP 29.42
- Support Level
- LGCB $2.20
- ADAP $0.05
- Resistance Level
- LGCB $2.51
- ADAP $0.09
- Average True Range (ATR)
- LGCB 0.09
- ADAP 0.01
- MACD
- LGCB -0.04
- ADAP 0.00
- Stochastic Oscillator
- LGCB 27.87
- ADAP 7.21
About LGCB Linkage Global Inc
Linkage Global Inc is a cross-border e-commerce integrated service provider. It provides international e-commerce merchants, overseas brands, import and export trading enterprises, etc. with a globally selected supply chain, digital marketing, e-commerce training, international store, ERP and e-commerce software, social e-commerce and other e-commerce integrated services. The Company has two operating segments: Extend from Japan, and Other Subsidiaries from Hong Kong. The company is Committed to building a one-stop cross-border integrated service platform to make cross-border trade easier. Company operates in Japan, Hong Kong and China, with maximum revenue from Japan.
About ADAP Adaptimmune Therapeutics plc
Adaptimmune Therapeutics PLC is a commercial-stage biopharmaceutical company working to redefine the treatment of solid tumor cancers with cell therapies. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70, and others for multiple cancer types.